JP2018201345A - Composition containing liver hydrolyzate and houttuynia cordata extract - Google Patents

Composition containing liver hydrolyzate and houttuynia cordata extract Download PDF

Info

Publication number
JP2018201345A
JP2018201345A JP2017106825A JP2017106825A JP2018201345A JP 2018201345 A JP2018201345 A JP 2018201345A JP 2017106825 A JP2017106825 A JP 2017106825A JP 2017106825 A JP2017106825 A JP 2017106825A JP 2018201345 A JP2018201345 A JP 2018201345A
Authority
JP
Japan
Prior art keywords
liver hydrolyzate
extract
liver
hydrolyzate
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017106825A
Other languages
Japanese (ja)
Other versions
JP6849281B2 (en
Inventor
礼子 鈴木
Reiko Suzuki
礼子 鈴木
倫希 金
Yunhi Kang
倫希 金
亮介 石田
Ryosuke Ishida
亮介 石田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
House Wellness Foods Corp
Original Assignee
House Wellness Foods Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by House Wellness Foods Corp filed Critical House Wellness Foods Corp
Priority to JP2017106825A priority Critical patent/JP6849281B2/en
Publication of JP2018201345A publication Critical patent/JP2018201345A/en
Application granted granted Critical
Publication of JP6849281B2 publication Critical patent/JP6849281B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

To provide a liquid composition containing a liver hydrolyzate in which an unpleasant odor and an impure taste typical of the liver hydrolyzate are reduced and which can be easily ingested.SOLUTION: A liquid composition containing a liver hydrolyzate of this invention includes the liver hydrolyzate and a Houttuynia Cordata (Dokudami) extract such that the Dokudami extract calculated in terms of original raw medicine is included in a ratio of 21.7-6500 pts.mass relative to 100 pts.mass of the liver hydrolyzate and has a pH value of 4.0 or less.SELECTED DRAWING: Figure 1

Description

本発明は、肝臓加水分解物に特有の不快臭及び雑味が低減された肝臓加水分解物含有液状組成物に関する。   The present invention relates to a liver hydrolyzate-containing liquid composition with reduced unpleasant odor and miscellaneous taste peculiar to liver hydrolyzate.

肝臓加水分解物は、ウシやブタなどの肝臓の加水分解物であり、肝臓機能を改善し、アルコール摂取時における体内のアセトアルデヒドの代謝を促進する作用を有することが知られている。そのため、肝臓加水分解物は、二日酔いの予防や軽減のほか、滋養強壮、貧血の改善、肌荒れの改善を目的とした医薬品や栄養補助剤(サプリメント)等に使用されており、特に日常的に手軽に摂取できるドリンク剤や内服液などの飲料形態で提供されている(特許文献1等)。しかしながら、肝臓加水分解物は、生物の肝臓を基原原料としていることから、肉特有の生臭み、焦げ感、旨味、後味の残り感があり、肝臓加水分解物を飲料に使用した場合には、これらの肝臓加水分解物に特有の不快臭や雑味が感じられて摂取しにくいという問題があった。   Liver hydrolyzate is a hydrolyzate of livers such as cattle and pigs, and is known to have an action of improving liver function and promoting metabolism of acetaldehyde in the body when ingesting alcohol. For this reason, liver hydrolysates are used in medicines and nutritional supplements (supplements) for the purpose of preventing and reducing hangovers, nutritional tonics, improving anemia, and rough skin. It is provided in the form of beverages such as drinks and internal liquids that can be ingested (Patent Document 1, etc.). However, since the liver hydrolyzate is based on the liver of the living organism, there is a raw odor, a burning sensation, a umami taste, and a feeling of aftertaste that is unique to meat. When liver hydrolyzate is used in beverages, However, there is a problem that unpleasant odor and miscellaneous taste peculiar to these liver hydrolysates are felt and it is difficult to take them.

肝臓加水分解物を含有する臓器製剤特有の不快な味と臭いを抑えるための手段として、L−アスパラギン酸ナトリウムおよびプラム系フレーバーもしくはシトラス系フレーバーを配合することが提案されているが(特許文献2)、その異質な風味のマスキング効果は十分ではなかった。また、特許文献3には、ウコンエキスを所定の比率で配合し、pHを所定範囲とすることで、肝臓加水分解物に特有の不快臭及び雑味を低減することが開示されている。
一方、ドクダミ(ジュウヤク)エキスは生薬成分として知られている(特許文献4等)。
As means for suppressing the unpleasant taste and odor peculiar to organ preparations containing liver hydrolysates, it has been proposed to blend sodium L-aspartate and plum or citrus flavors (Patent Document 2). ) The masking effect of the extraordinary flavor was not sufficient. Patent Document 3 discloses that an unpleasant odor and miscellaneous taste peculiar to liver hydrolyzate are reduced by blending turmeric extract at a predetermined ratio and adjusting the pH within a predetermined range.
On the other hand, dokudami (juyaku) extract is known as a herbal medicine component (Patent Document 4 etc.).

特開2013−95670号公報JP 2013-95670 A 特開平5−163154号公報JP-A-5-163154 特許第5595614号公報Japanese Patent No. 5595614 国際公開WO03/024466International Publication WO03 / 024466

本発明の課題は、肝臓加水分解物の特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物を提供することにある。   An object of the present invention is to provide a liver hydrolyzate-containing liquid composition that is reduced in the unpleasant odor and miscellaneous peculiarity of liver hydrolyzate and is easy to take.

本発明者らは上記課題を解決すべく鋭意研究を重ねた結果、肝臓加水分解物とドクダミエキスとを所定の比率で配合することにより、肝臓加水分解物の特有の不快臭及び雑味が低減され、摂取しやすい液状組成物を提供できることを見出し、本発明を完成するに至った。   As a result of intensive studies to solve the above-mentioned problems, the present inventors have reduced the unpleasant odor and miscellaneous taste peculiar to liver hydrolysates by blending liver hydrolyzate and dokudami extract in a predetermined ratio. The present inventors have found that a liquid composition that can be easily ingested can be provided, and have completed the present invention.

具体的には本発明は以下の発明を提供する。
(1)肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比で含有し、かつ、pHが4.0以下である肝臓加水分解物含有液状組成物。
(2)(1)に記載の液状組成物が入れられた、容器詰飲料。
(3)肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように原料液に配合する工程を含む、pHが4.0以下である肝臓加水分解物含有液状組成物の製造方法。
(4)肝臓加水分解物を含有する原料液に、ドクダミエキスを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように配合することによって、肝臓加水分解物含有液状組成物の不快臭及び雑味を低減する方法。
Specifically, the present invention provides the following inventions.
(1) A docami extract obtained by converting a liver hydrolyzate and a docami extract into a crude drug equivalent to 100 parts by mass of the liver hydrolyzate in a ratio of 21.7 to 6500 parts by mass, and a pH of 4.0. A liver hydrolyzate-containing liquid composition which is:
(2) A packaged beverage containing the liquid composition according to (1).
(3) The process which mix | blends a liver hydrolyzate and dokudami extract with a raw material liquid so that the ratio of 21.7-6500 mass parts of dokudami extract which converted the crude drug with respect to 100 mass parts of liver hydrolysates may be set. A method for producing a liver hydrolyzate-containing liquid composition having a pH of 4.0 or less.
(4) In the raw material liquid containing liver hydrolyzate, dokudami extract is blended so that the ratio of 21.7 to 6500 parts by weight of dokudami extract in terms of active ingredient is based on 100 parts by weight of liver hydrolyzate. The method of reducing the unpleasant odor and miscellaneous taste of a liquid composition containing a liver hydrolyzate.

本発明によれば、肝臓加水分解物に特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物が提供される。   ADVANTAGE OF THE INVENTION According to this invention, the unpleasant odor and miscellaneous taste peculiar to a liver hydrolyzate are reduced, and the liver hydrolyzate containing liquid composition easy to ingest is provided.

実施例1(ドクダミエキス6500質量部/肝臓加水分解物100質量部、pH3.6)、比較例1(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。The evaluation score in the sensory test of the beverage composition of Example 1 (6500 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.6) and Comparative Example 1 (liver hydrolyzate only, pH 3.6) is shown. . 実施例2(ドクダミエキス21.7質量部/肝臓加水分解物100質量部、pH3.6)、比較例2(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。Evaluation score in the sensory test of the beverage composition of Example 2 (Dokudami extract 21.7 parts by weight / 100 parts by weight of liver hydrolyzate, pH 3.6) and Comparative Example 2 (liver hydrolyzate only, pH 3.6) Indicates. 実施例3(ドクダミエキス54.2質量部/肝臓加水分解物100質量部、pH3.6)、比較例2(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。Evaluation score in sensory test of beverage composition of Example 3 (54.2 parts by weight of wolfberry extract / 100 parts by weight of liver hydrolyzate, pH 3.6) and Comparative Example 2 (only liver hydrolyzate, pH 3.6) Indicates. 実施例4(ドクダミエキス108質量部/肝臓加水分解物100質量部、pH3.6)、比較例2(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。The evaluation score in the sensory test of the beverage composition of Example 4 (108 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.6) and Comparative Example 2 (liver hydrolyzate only, pH 3.6) is shown. . 実施例5(ドクダミエキス217質量部/肝臓加水分解物100質量部、pH3.6)、比較例2(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。The evaluation score in the sensory test of the beverage composition of Example 5 (217 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.6) and Comparative Example 2 (liver hydrolyzate only, pH 3.6) is shown. . 実施例4(ドクダミエキス108質量部/肝臓加水分解物100質量部、pH3.6)、実施例6(ドクダミエキス108質量部/肝臓加水分解物100質量部、pH3.0)、実施例7(ドクダミエキス108質量部/肝臓加水分解物100質量部、pH4.0)、比較例2(肝臓加水分解物のみ、pH3.6)の飲料組成物の官能試験での評価点数を示す。Example 4 (108 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.6), Example 6 (108 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.0), Example 7 ( The evaluation score in the sensory test of the beverage composition of 108 parts by weight of dokudami extract / 100 parts by weight of liver hydrolyzate, pH 4.0) and Comparative Example 2 (liver hydrolyzate only, pH 3.6) is shown. 実施例4(ドクダミエキス108質量部/肝臓加水分解物100質量部、pH3.6)、比較例2(肝臓加水分解物のみ)、比較例3(肝臓加水分解物とグレープフルーツフレーバー)、比較例4(肝臓加水分解物とテンチャエキス)、比較例5(肝臓加水分解物とマッチャエキス)の飲料組成物の官能試験での評価点数を示す。Example 4 (108 parts by weight of Dokudami extract / 100 parts by weight of liver hydrolyzate, pH 3.6), Comparative Example 2 (liver hydrolyzate only), Comparative Example 3 (liver hydrolyzate and grapefruit flavor), Comparative Example 4 The evaluation score in the sensory test of the beverage composition of (liver hydrolyzate and tencha extract) and comparative example 5 (liver hydrolyzate and matcher extract) is shown.

1.肝臓加水分解物
本発明において肝臓加水分解物とは、ウシやブタなどの動物の肝臓を、消化酵素(タンパク質分解酵素)を用いて分解した分解生成物をいう。肝臓加水分解物は、肝臓水解物、肝臓エキスとも称され、本発明の肝臓加水分解物は、肝臓水解物、肝臓エキスと表記されるものを包含する概念である。
1. Liver hydrolyzate In the present invention, the liver hydrolyzate refers to a decomposition product obtained by decomposing the liver of an animal such as a cow or pig using a digestive enzyme (proteolytic enzyme). The liver hydrolyzate is also referred to as liver hydrolyzate or liver extract, and the liver hydrolyzate of the present invention is a concept including those expressed as liver hydrolyzate and liver extract.

2.ドクダミエキス
本発明においてドクダミエキスは、ドクダミから水溶性溶媒を用いて抽出し、加熱及び/又は減圧して抽出溶媒を揮発させることにより得ることができる。ここで用いる水溶性溶媒としては、アルコール等の水溶性有機溶媒や水が挙げられ、水と水溶性有機溶媒との混合溶媒でもよい。
2. Dokudami Extract In the present invention, the Dokudami Extract can be obtained by extracting water from a Dokudami using a water-soluble solvent and volatilizing the extraction solvent by heating and / or reducing pressure. Examples of the water-soluble solvent used here include water-soluble organic solvents such as alcohol and water, and a mixed solvent of water and a water-soluble organic solvent may be used.

3.肝臓加水分解物とドクダミエキスとの比
本発明の液状組成物における肝臓加水分解物とドクダミエキスの配合比は、肝臓加水分解物100質量部に対して、原生薬換算したドクダミエキスが21.7〜6500質量部であることが好ましく、50〜500質量部であることがより好ましく、50〜200質量部であることが特に好ましい。
3. Ratio of Liver Hydrolyzate and Dokudami Extract The mixing ratio of liver hydrolyzate and Dokudami extract in the liquid composition of the present invention was 21.7% of Dokudami Extract converted to the active ingredient with respect to 100 parts by mass of liver hydrolyzate. It is preferably ˜6500 parts by mass, more preferably 50 to 500 parts by mass, and particularly preferably 50 to 200 parts by mass.

肝臓加水分解物とドクダミエキスの配合比がこの範囲内であると、肝臓加水分解物に特有の不快臭及び雑味が感じられず、肝臓加水分解物含有液状組成物の風味や味を良好なものとすることができる。ここで、肝臓加水分解物に特有の不快臭及び雑味とは、肉特有の生臭み、肉特有の焦げ感、肉特有の旨味、肉特有の後味の残り感をいう。   When the blending ratio of the liver hydrolyzate and the Dokudami extract is within this range, the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate are not felt, and the flavor and taste of the liver hydrolyzate-containing liquid composition are good. Can be. Here, the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate refer to the raw odor peculiar to meat, the charcoal peculiar feeling of meat, the peculiar taste of meat, and the residual feeling of the aftertaste peculiar to meat.

また、本発明の液状組成物における肝臓加水分解物とドクダミエキスの配合量は、上記の配合比の範囲である限り特に限定はされない。例えば、肝臓加水分解物の配合量は、組成物全量に対し、0.01〜2.0質量%、好ましくは0.1〜1.0質量%が例示でき、ドクダミエキスの配合量は、肝臓加水分解物の配合量に対して上記の配合比となるように決定することができる。   Moreover, the compounding quantity of the liver hydrolyzate and a docami extract in the liquid composition of this invention will not be specifically limited as long as it is the range of said compounding ratio. For example, the compounding amount of the liver hydrolyzate can be exemplified by 0.01 to 2.0% by mass, preferably 0.1 to 1.0% by mass, with respect to the total amount of the composition, It can determine so that it may become said compounding ratio with respect to the compounding quantity of a hydrolyzate.

4.他の成分
本発明の液状組成物は、水に上記の肝臓加水分解物とドクダミエキスを配合するものであるが、一又は複数の他の成分を更に含有してもよい。他の成分は飲食品や医薬品などの最終的な形態において許容される成分であって、経口摂取可能な成分であれば特に限定はされないが、例えば、甘味料、環状オリゴ糖、酸味料、増粘剤、ビタミン類、香料、香辛料抽出物、酸化防止剤、乳化剤等が例示できる。
4). Other components Although the liquid composition of this invention mix | blends said liver hydrolyzate and a Dokudami extract in water, you may further contain one or several other components. The other components are components that are acceptable in the final form such as foods and drinks and pharmaceuticals, and are not particularly limited as long as they can be taken orally. For example, sweeteners, cyclic oligosaccharides, acidulants, Examples thereof include viscous agents, vitamins, fragrances, spice extracts, antioxidants, and emulsifiers.

甘味料としては、ショ糖、果糖、ブドウ糖、液糖、はちみつ等の糖類、スクラロース、アセスルファムカリウム、ソーマチン、アスパルテーム、ステビア等の高甘味度甘味料が挙げられる。   Examples of the sweetener include sugars such as sucrose, fructose, glucose, liquid sugar and honey, and high-intensity sweeteners such as sucralose, acesulfame potassium, thaumatin, aspartame and stevia.

酸味料としては、クエン酸の他に、リンゴ酸、グルコン酸、酒石酸、乳酸、リン酸、あるいはこれらの塩等が挙げられる。   Examples of the acidulant include malic acid, gluconic acid, tartaric acid, lactic acid, phosphoric acid, and salts thereof in addition to citric acid.

増粘剤としては、ジェランガム、発酵セルロース、キサンタンガム、アラビアガム、タマリンドガム、グアガム、ローカストビーンガム、カラヤガム、タラガム、寒天、ゼラチン、ペクチン、大豆多糖類、CMC(カルボキシメチルセルロース)、カラギナン、微結晶セルロース、アルギン酸プロピレングリコールエステル等が挙げられる。   Thickeners include gellan gum, fermented cellulose, xanthan gum, gum arabic, tamarind gum, guar gum, locust bean gum, karaya gum, tara gum, agar, gelatin, pectin, soy polysaccharide, CMC (carboxymethylcellulose), carrageenan, microcrystalline cellulose And alginic acid propylene glycol ester.

ビタミン類としては、ビタミンC、ビタミンB1、ビタミンB6,ビタミンE、ナイアシン、イノシトール等が挙げられる。   Examples of vitamins include vitamin C, vitamin B1, vitamin B6, vitamin E, niacin, inositol, and the like.

酸化防止剤としては、ビタミンC、ビタミンE、酵素処理ルチン、カテキン等が挙げられる。   Examples of the antioxidant include vitamin C, vitamin E, enzyme-treated rutin, catechin and the like.

乳化剤としては、グリセリン脂肪酸エステル、レシチン、植物性ステロール、サポニン等が挙げられる。   Examples of the emulsifier include glycerin fatty acid ester, lecithin, vegetable sterol, and saponin.

香辛料抽出物としては、ウコンエキス、ウコン色素等のウコン抽出物が例示できる。ウコンエキスは、ビサクロンを含有する水溶性ウコン抽出物を指す。ウコン色素は、クルクミノイドを含有する油溶性ウコン抽出物を指す。ウコンエキスとウコン色素とを合わせて用いてもよい。   Examples of the spice extract include turmeric extracts such as turmeric extract and turmeric pigment. Turmeric extract refers to a water-soluble turmeric extract containing bisaclone. Turmeric pigment refers to an oil-soluble turmeric extract containing curcuminoids. A turmeric extract and a turmeric pigment may be used in combination.

上記他の成分は、それぞれ当業者が飲料等の液状組成物に通常採用する範囲内の量で適宜配合することができる。   The above-mentioned other components can be appropriately blended in an amount within the range usually employed by those skilled in the art for liquid compositions such as beverages.

5.液状組成物のpH
本発明の液状組成物のpHはpH4.0以下が好ましい。本発明においてpH値は品温20℃で測定された値を指す。pH値が4.0よりも高い場合には肝臓加水分解物の特有の不快臭及び雑味の低減効果が得られないという問題がある。また、本発明の組成物が清涼飲料水の形態である場合には、当該pH値の上限をpH4.0未満とすることができる。pH値の下限は特に限定されず、2.3以上、好ましくは3.0以上、さらに好ましくは3.1以上とすることができる。
5. PH of liquid composition
The pH of the liquid composition of the present invention is preferably pH 4.0 or less. In the present invention, the pH value refers to a value measured at a product temperature of 20 ° C. When the pH value is higher than 4.0, there is a problem that the effect of reducing the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate cannot be obtained. Moreover, when the composition of this invention is a form of a soft drink, the upper limit of the said pH value can be made into pH less than 4.0. The lower limit of the pH value is not particularly limited, and can be 2.3 or more, preferably 3.0 or more, and more preferably 3.1 or more.

本発明の組成物のpHの調整は、上記原料を混合し、必要に応じて適宜酸味料を加えることにより行う。酸味料としては、前記の一般的に使用される有機もしくは無機の食用酸またはそれらの塩を用いればよい。酸味料の使用量は、所望のpHとすることができ、かつ組成物の風味に影響がない範囲であれば特に限定されない。   Adjustment of pH of the composition of this invention is performed by mixing the said raw material and adding a sour agent suitably as needed. As the acidulant, the above-mentioned generally used organic or inorganic edible acids or salts thereof may be used. The amount of acidulant used is not particularly limited as long as it can be set to a desired pH and does not affect the flavor of the composition.

本発明の液状組成物は、液状食品(飲料)として提供されてもよいし、液状の経口投与用の医薬品(内服液)として提供されてもよいが、好ましくは飲料である。また、飲料は、嗜好性により、炭酸を含む炭酸飲料、ゲル化剤(デンプン、寒天、増粘剤等)を含むゼリー飲料としてもよい。   The liquid composition of the present invention may be provided as a liquid food (beverage) or a liquid pharmaceutical for oral administration (internal liquid), but is preferably a beverage. The beverage may be a carbonated beverage containing carbonic acid or a jelly beverage containing a gelling agent (starch, agar, thickener, etc.) depending on palatability.

6.液状組成物の製造方法
本発明の液状組成物は、水を基調とする組成物であり、上記の各成分を水と混合して製造することができる。本発明の液状組成物の製造方法は、肝臓加水分解物とドクダミエキスを最終的な液状組成物において上記比となるように原料液に配合する工程を少なくとも含んでいればよく、その他の工程は飲料の通常の製造方法に従う。各成分を配合した原料液は、必要によりpHを4.0以下に調整し、65〜100℃に加熱して殺菌処理を行い、飲料用容器に充填密封することにより加熱殺菌済みの殺菌された容器詰め液状組成物製品とすることができる。
6). Method for Producing Liquid Composition The liquid composition of the present invention is a composition based on water, and can be produced by mixing each of the above components with water. The method for producing the liquid composition of the present invention only needs to include at least a step of blending the liver hydrolyzate and the docami extract into the raw material liquid so as to have the above ratio in the final liquid composition. Follow the normal method for making beverages. The raw material liquid containing each component was adjusted to pH 4.0 or lower as necessary, sterilized by heating to 65 to 100 ° C., and sterilized by heat sterilization by filling and sealing in a beverage container. It can be set as a container-packed liquid composition product.

飲料用容器としては、ポリエチレンテレフタレート(PET)製容器、金属缶、金属箔やプラスチックフィルムと複合された紙容器、ガラス瓶が挙げられ、容器の形態は特に限定されない。また、容器の容量は特に限定されないが、例えば100ml〜500ml(典型的には100ml、150ml、200ml、250ml、300ml、350ml、400ml、450ml又は500ml)とすることができる。液状組成物を容器に収容する手段は任意である。   Examples of the beverage container include a polyethylene terephthalate (PET) container, a metal can, a paper container combined with a metal foil or a plastic film, and a glass bottle, and the form of the container is not particularly limited. The capacity of the container is not particularly limited, but can be, for example, 100 ml to 500 ml (typically 100 ml, 150 ml, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml or 500 ml). The means for accommodating the liquid composition in the container is arbitrary.

本発明の液状組成物は肝臓加水分解物特有の不快臭及び雑味が低減された肝臓加水分解物含有組成物である。本発明の液状組成物は、例えば、アルコール摂取後の起床時のいわゆる二日酔い症状(特に、頭重感、アルコール残り感、胃の不快症状)の軽減作用を有する飲食品組成物や医薬品組成物として使用できる。   The liquid composition of the present invention is a liver hydrolyzate-containing composition with reduced unpleasant odor and miscellaneous taste peculiar to liver hydrolysates. The liquid composition of the present invention is used, for example, as a food / beverage composition or a pharmaceutical composition having an action to reduce so-called hangover symptoms (particularly, head sensation, feeling of residual alcohol, stomach discomfort) upon waking up after alcohol consumption it can.

以下、実施例によって本発明を更に具体的に説明するが、これらの実施例は本発明を限定するものでない。   EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples, but these examples do not limit the present invention.

1.試験飲料の調製
各試験飲料は、表1、2に示す配合量にて、水以外の成分(粉末原料)を混合した後、水に添加溶解して、液体原料を投入して全量100gの水溶液とした。各試験飲料のpHはクエン酸にて調整した。表中のpH値は品温20℃で測定された値を示す。表中の各成分の単位は質量(g)である。
1. Preparation of test beverages Each test beverage was mixed with ingredients other than water (powder raw material) in the blending amounts shown in Tables 1 and 2, and then added and dissolved in water. It was. The pH of each test beverage was adjusted with citric acid. The pH value in the table indicates a value measured at a product temperature of 20 ° C. The unit of each component in the table is mass (g).

本試験で使用したドクダミエキスは、ドクダミエキス1kgあたり原生薬(ドクダミ乾燥物)6.5kgから製造されたものである。   The dokudami extract used in this test was produced from 6.5 kg of the crude drug (dried dokudami) per kg of dokudami extract.

Figure 2018201345
Figure 2018201345

Figure 2018201345
Figure 2018201345

2.試験(官能評価)方法
試験は、20歳以上50歳以下の健常な男女7名をパネラーとして選定し、官能評価を行なった。パネラーは各試験飲料を摂取し、「肉特有の生臭み」、「肉特有の焦げ感」、「肉特有の旨味」、「肉特有の後味の残り感」の項目について0〜10段階(0:弱い、10:強い)での評価を行なった。なお、結果は、各試験飲料におけるパネラー評価の平均値を示した。
2. Test (Sensory Evaluation) Method In the test, seven healthy men and women aged 20 to 50 were selected as panelists to perform sensory evaluation. The panelist ingested each test beverage, and 0 to 10 levels (0 for the items of “meat-specific odor”, “meat-specific scorch”, “meat-specific umami”, “meat-specific aftertaste”) : Weak, 10: strong). In addition, the result showed the average value of the paneler evaluation in each test drink.

3.官能試験結果
3.1.肝臓加水分解物とドクダミエキス(原生薬換算)の配合比
実施例1(肝臓加水分解物:ドクダミエキス(原生薬換算)=1:65(pH3.6)、実施例2(肝臓加水分解物:ドクダミエキス(原生薬換算)=30:6.5、pH3.6)、実施例3(肝臓加水分解物:ドクダミエキス(原生薬換算)=12:6.5、pH3.6)、および実施例4(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH3.6)、実施例5(肝臓加水分解物:ドクダミエキス(原生薬換算)=3:6.5、pH3.6)の試験飲料のパネラーによる官能評価試験の結果をそれぞれ図1、図2、図3、図4、図5に示す。各実施例の結果は、同量の肝臓加水分解物を配合し、ドクダミエキスは含まない試験飲料(比較例1、2)と比較し、同じ図に示した。図1〜5に示すように、肝臓加水分解物とともにドクダミエキスを配合した試験飲料(実施例1〜5)では、いずれも肝臓加水分解物特有の生臭み・焦げ感・旨味・後味の残り感が低減され、肝臓加水分解物特有の異質な風味が改善された。これらの結果から、肝臓加水分解物とドクダミエキス(原生薬換算)の含有比が質量比で1:65〜30:6.5である場合に効果があるといえる。
3. Sensory test results 3.1. Mixing ratio of liver hydrolyzate and dokudami extract (raw substance conversion) Example 1 (liver hydrolyzate: dokudami extract (raw drug conversion) = 1: 65 (pH 3.6), Example 2 (liver hydrolyzate: Docami extract (converted as crude drug) = 30: 6.5, pH 3.6), Example 3 (liver hydrolyzate: docami extract (converted as drug substance) = 12: 6.5, pH 3.6), and Examples 4 (liver hydrolyzate: dokudami extract (in terms of drug substance) = 6: 6.5, pH 3.6), Example 5 (liver hydrolyzate: dokudami extract (in terms of drug substance)) = 3: 6.5, pH 3 The results of sensory evaluation tests by panelists of test drinks of 6) are shown in Fig. 1, Fig. 2, Fig. 3, Fig. 4 and Fig. 5. The results of each example are the same amount of liver hydrolyzate. , Compared with the test beverages (Comparative Examples 1 and 2) that do not contain the Dokudami extract, As shown in FIGS. 1 to 5, in the test beverages (Examples 1 to 5) in which the docomami extract was blended with the liver hydrolyzate, all of the live smell, scorch, The remaining taste of umami and aftertaste was reduced, and the unusual flavor unique to liver hydrolyzate was improved.From these results, the content ratio of liver hydrolyzate and dokudami extract (in terms of crude drug) is 1: It can be said that it is effective when it is 65-30: 6.5.

3.2.pHの範囲
実施例6(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH3.0)、実施例7(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH4.0)の試験飲料のパネラーによる官能評価試験の結果を図6に示す。各実施例の結果は、同量の肝臓加水分解物を配合し、ドクダミエキスは含まない試験飲料(比較例2)と比較し、同じ図に示した。図6に示すように、肝臓加水分解物とともにドクダミエキスを配合し、かつpHを3.0または4.0に調整した試験飲料(実施例6、7)では、いずれも肝臓加水分解物特有の生臭み・焦げ感・旨味・後味の残り感が低減され、肝臓加水分解物特有の異質な風味が改善された。これらの結果と前記実施例1〜5の結果を合わせると、pHが4.0以下である場合に効果があるといえる。
3.2. Range of pH Example 6 (liver hydrolyzate: dokudami extract (concentration of crude drug) = 6: 6.5, pH 3.0), Example 7 (liver hydrolyzate: dokudami extract (concentration of drug substance) = 6: The result of the sensory evaluation test by the panel of the test drink of 6.5, pH 4.0) is shown in FIG. The result of each Example was shown in the same figure compared with the test drink (comparative example 2) which mix | blended the same amount of liver hydrolyzate and does not contain a docami extract. As shown in FIG. 6, in the test beverages (Examples 6 and 7) in which the docami extract was blended with the liver hydrolyzate and the pH was adjusted to 3.0 or 4.0, both were specific to the liver hydrolyzate. The raw odor, burning, umami, and aftertaste are reduced, and the unusual flavor unique to liver hydrolysates is improved. When these results and the results of Examples 1 to 5 are combined, it can be said that there is an effect when the pH is 4.0 or less.

3.3.他のマスキング剤の効果
ドクダミエキスと同様に苦味のある、グレープフルーツフレーバー(ナリンギン13〜15.5%含有)、テンチャエキス、マッチャエキスの効果を試験した。比較例3(肝臓加水分解物:グレープフルーツフレーバー=0.6:0.1、pH3.6)、比較例4(肝臓加水分解物:テンチャエキス=0.6:1.5、pH3.6)、比較例5(肝臓加水分解物:マッチャエキス=0.6:0.15の試験飲料のパネラーによる官能評価試験の結果を図7に示す。各試験の結果は、同量の肝臓加水分解物のみを含む試験飲料(比較例2)と比較した。図7に示すように、肝臓加水分解物特有の生臭み・焦げ感・後味の残り感を低減し、肝臓加水分解物特有の異質な風味を改善する効果が認められるのはドクダミエキスだという結果が得られた。これらの結果より、単なる苦味成分を配合するだけでは肝臓加水分解物の異質な風味をマスキングできないといえる。
3.3. Effects of other masking agents The effects of grapefruit flavor (containing 13 to 15.5% naringin), tencha extract, and matcher extract having a bitter taste similar to those of docami extract were tested. Comparative Example 3 (liver hydrolyzate: grapefruit flavor = 0.6: 0.1, pH 3.6), Comparative Example 4 (liver hydrolyzate: tencha extract = 0.6: 1.5, pH 3.6), The result of the sensory evaluation test by the panelist of the test drink of Comparative Example 5 (liver hydrolyzate: matcher extract = 0.6: 0.15 is shown in FIG. 7. The result of each test is the same amount of liver hydrolyzate only. As shown in Fig. 7, it reduces the raw smell, burnt feeling and residual feeling of the aftertaste peculiar to the liver hydrolyzate, and has the extraordinary flavor peculiar to the liver hydrolyzate. The results showed that the effect of improvement was found to be the dokudami extract, and it can be said from these results that it is not possible to mask the heterogeneous flavor of the liver hydrolyzate by simply adding a bitter component.

4.飲料の配合例
本発明の飲料組成物の具体的な配合の一例を表3に示す。
水以外の成分(粉末原料)を混合した後、水に添加溶解して、液体原料を投入して全量100gの水溶液とした。表中の各成分の単位は質量(g)である。
4). Table 3 shows an example of a specific formulation of the beverage composition of the present invention.
Components other than water (powder raw material) were mixed, then added and dissolved in water, and the liquid raw material was added to make a total amount of 100 g of an aqueous solution. The unit of each component in the table is mass (g).

Figure 2018201345
Figure 2018201345

本発明によれば、肝臓加水分解物に特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物が提供される。従って、本発明は、飲料や内服液の製造分野において利用できる。   ADVANTAGE OF THE INVENTION According to this invention, the unpleasant odor and miscellaneous taste peculiar to a liver hydrolyzate are reduced, and the liver hydrolyzate containing liquid composition easy to ingest is provided. Therefore, this invention can be utilized in the manufacture field | area of a drink or an internal use liquid.

Claims (4)

肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比で含有し、かつ、pHが4.0以下である肝臓加水分解物含有液状組成物。   The liver hydrolyzate and dokudami extract are contained in a ratio of 21.7 to 6500 parts by weight of dokudami extract in terms of active ingredient based on 100 parts by weight of liver hydrolyzate, and the pH is 4.0 or less. Liver hydrolyzate-containing liquid composition. 請求項1に記載の液状組成物が入れられた、容器詰飲料。   A packaged beverage containing the liquid composition according to claim 1. 肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように原料液に配合する工程を含む、pHが4.0以下である肝臓加水分解物含有液状組成物の製造方法。   Including a step of blending the liver hydrolyzate and docami extract into the raw material liquid so that the ratio of 21.7 to 6500 parts by mass of the docami extract converted to the active ingredient is 100 parts by mass of the liver hydrolyzate, A method for producing a liver hydrolyzate-containing liquid composition having a pH of 4.0 or less. 肝臓加水分解物を含有する原料液に、ドクダミエキスを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように配合することによって、肝臓加水分解物含有液状組成物の不快臭及び雑味を低減する方法。   By blending dokudami extract into raw material liquid containing liver hydrolyzate so that the ratio of 21.7 to 6500 parts by weight of dokudami extract in terms of active ingredient with respect to 100 parts by weight of liver hydrolyzate, The method to reduce the unpleasant odor and miscellaneous taste of a liver hydrolyzate containing liquid composition.
JP2017106825A 2017-05-30 2017-05-30 Composition containing liver hydrolyzate and Houttuynia cordata extract Active JP6849281B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017106825A JP6849281B2 (en) 2017-05-30 2017-05-30 Composition containing liver hydrolyzate and Houttuynia cordata extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017106825A JP6849281B2 (en) 2017-05-30 2017-05-30 Composition containing liver hydrolyzate and Houttuynia cordata extract

Publications (2)

Publication Number Publication Date
JP2018201345A true JP2018201345A (en) 2018-12-27
JP6849281B2 JP6849281B2 (en) 2021-03-24

Family

ID=64954188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017106825A Active JP6849281B2 (en) 2017-05-30 2017-05-30 Composition containing liver hydrolyzate and Houttuynia cordata extract

Country Status (1)

Country Link
JP (1) JP6849281B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015091768A (en) * 2013-09-30 2015-05-14 ハウス食品グループ本社株式会社 Liver hydrolysate-containing liquid composition
JP2016216441A (en) * 2015-05-20 2016-12-22 ゼリア新薬工業株式会社 Liquid agent for internal use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015091768A (en) * 2013-09-30 2015-05-14 ハウス食品グループ本社株式会社 Liver hydrolysate-containing liquid composition
JP2016216441A (en) * 2015-05-20 2016-12-22 ゼリア新薬工業株式会社 Liquid agent for internal use

Also Published As

Publication number Publication date
JP6849281B2 (en) 2021-03-24

Similar Documents

Publication Publication Date Title
JP5595614B1 (en) Liver hydrolyzate-containing liquid composition
US20090169682A1 (en) Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same
KR101367741B1 (en) Compositions comprising garcinia cambogia extract and methods for preparing the same
CN106061479B (en) Weak prophylactic
CN105211481A (en) Tasty and refreshing sugar of a kind of agate card prebiotics sugar-free and preparation method thereof
JP5921143B2 (en) Flavor improving agent for beverages containing ginger
JP2020150953A (en) Beverage
CN112120221A (en) High calorie nutritional composition
JP2015173631A (en) Packed carbonated beverage containing star anise extract
JP2010063390A (en) Food and drink
JP5355809B1 (en) Beverage
JP2015063520A (en) Salivary secretion promoter
JP6849281B2 (en) Composition containing liver hydrolyzate and Houttuynia cordata extract
JP6840647B2 (en) Liquid composition, its cloudiness improving agent, odor improving agent, and manufacturing method
JP6161595B2 (en) Beverage
JPH10179077A (en) Bitter taste masking agent
JP6686292B2 (en) Amino acid-containing composition
JP7336970B2 (en) Paffia-containing acidic food and drink
JP5998351B2 (en) Composition for preventing or improving snoring
JP2011231051A (en) Oral jelly preparation containing vitamin b1
JP6178196B2 (en) Alanine-containing liquid composition
JP2017193532A (en) Composition for improving bone density, food composition for improving bone density, composition for improving liver function, and food composition for improving liver function
JP6758619B2 (en) Composition
JP6261263B2 (en) Turmeric extract-containing beverage
JP2019198233A (en) Qol improving or maintaining agent on mental aspect

Legal Events

Date Code Title Description
A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20200219

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210202

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210302

R150 Certificate of patent or registration of utility model

Ref document number: 6849281

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250